iCoat Medical
Therapeutics preventing organ transplant injury
Visit iCoat MedicalInvestment amounts are not disclosed by MTC without authorization from the portfolio company.
About iCoat Medical
Biopharmaceutical company developing coating therapeutics to prevent ischemia-reperfusion injury during organ transplantation.
Industry
Biomedical & Life Sciences is one of MTC's seven IDEA Fund focus areas.Explore other Biomedical & Life Sciences companies →
Missouri Impact
Impact metrics such as jobs created, capital raised, and revenue will be displayed here using data provided by Missouri Technology Corporation. Individual metrics are only shown when verified from authoritative MTC sources.